ScholarIQanswers from OpenAlex
AstraZeneca (Finland)
InstitutionResearch output, impact & collaborations
AstraZeneca (Finland) is a institution indexed in ScholarIQ from OpenAlex.
What is known about AstraZeneca (Finland)?
ScholarIQrecord summary
AstraZeneca (Finland) is a research organisation in Espoo, FI. OpenAlex records 1,387 works and 98,466 citations for it. 871 researchers list it as their most recent affiliation.
How many works does AstraZeneca (Finland) have?
ScholarIQindexed works
AstraZeneca (Finland) has 1,387 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does AstraZeneca (Finland) have?
ScholarIQcitation count
AstraZeneca (Finland) has 98,466 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at AstraZeneca (Finland)?
ScholarIQresearcher count
AstraZeneca (Finland) has 871 researchers in the ScholarIQ index.
What is the average h-index at AstraZeneca (Finland)?
ScholarIQavg h-index
AstraZeneca (Finland) has an average h-index of 52 in OpenAlex.
What is the ROR of AstraZeneca (Finland)?
ScholarIQror
The ROR for AstraZeneca (Finland) is on the source record.
What is the OpenAlex record for AstraZeneca (Finland)?
ScholarIQopenalex
The OpenAlex for AstraZeneca (Finland) is on the source record.
Who are the most-cited researchers behind AstraZeneca (Finland)?
ScholarIQtop researchers by citations
What are the most-cited papers on AstraZeneca (Finland)?
ScholarIQmost cited works
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J.L. Heerspink, Bergur V. Stefánsson, Ricardo Correa‐Rotter, Glenn M. Chertow, Tom Greene, Fan Fan Hou, Johannes F.E. Mann, John J.V. McMurray, Magnus Lindberg, Peter Rossing, C. David Sjöström, Roberto D. Toto, Anna-Maria Langkilde, David C. Wheeler
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Lars Sjöström, Kristina Narbro, C. David Sjöström, Kristjan Karason, Bo Larsson, Hans Wedel, Ted Lystig, Marianne Sullivan, Claude Bouchard, Björn Carlsson, Calle Bengtsson, S Dahlgren, Anders Gummesson, Peter Jacobson, Jan Karlsson, Anna‐Karin Lindroos, Hans Lönroth, Ingmar Näslund, Torsten Olbers, Kaj Stenlöf, Jarl Torgerson, Göran I. Ågren, Lena Carlsson
Bariatric Surgery and Long-term Cardiovascular Events
Lars Sjöström, Markku Peltonen, Peter Jacobson, C. David Sjöström, Kristjan Karason, Hans Wedel, Sofie Ahlin, Åsa Anveden, Calle Bengtsson, Gerd Bergmark, Claude Bouchard, Björn Carlsson, S Dahlgren, Jan Karlsson, Anna‐Karin Lindroos, Hans Lönroth, Kristina Narbro, Ingmar Näslund, Torsten Olbers, Per‐Arne Svensson, Lena Carlsson
Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial
Lars Sjöström, Anders Gummesson, C. David Sjöström, Kristina Narbro, Markku Peltonen, Hans Wedel, Calle Bengtsson, Claude Bouchard, Björn Carlsson, S Dahlgren, Peter Jacobson, Kristjan Karason, Jan Karlsson, Bo Larsson, Anna‐Karin Lindroos, Hans Lönroth, Ingmar Näslund, Torsten Olbers, Kaj Stenlöf, Jarl Torgerson, Lena Carlsson
Reduction in Incidence of Diabetes, Hypertension and Lipid Disturbances after Intentional Weight Loss Induced by Bariatric Surgery: the SOS Intervention Study
C. David Sjöström, Lauren Lissner, Hans Wedel, Lars Sjöström
How much of the research on AstraZeneca (Finland) is open access?
ScholarIQopen access share
75%OPEN ACCESS